Baldwin Wealth Partners’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-771
| Closed | -$77K | – | 572 |
|
|
2019
Q3 | $77K | Hold |
771
| – | – | 0.01% | 260 |
|
|
2019
Q2 | $71K | Sell |
771
-5
| -0.6% | -$475 | 0.01% | 278 |
|
|
2019
Q1 | $73K | Hold |
776
| – | – | 0.01% | 267 |
|
|
2018
Q4 | $50K | Hold |
776
| – | – | 0.01% | 292 |
|
|
2018
Q3 | $69K | Sell |
776
-20
| -3% | -$1.77K | 0.01% | 280 |
|
|
2018
Q2 | $63K | Sell |
796
-3,433
| -81% | -$285K | 0.01% | 289 |
|
|
2018
Q1 | $377K | Buy |
4,229
+1,900
| +82% | +$182K | 0.06% | 143 |
|
|
2017
Q4 | $243K | Sell |
2,329
-4,320
| -65% | -$487K | 0.04% | 184 |
|
|
2017
Q3 | $970K | Sell |
6,649
-21
| -0.3% | -$2.86K | 0.16% | 91 |
|
|
2017
Q2 | $866K | Sell |
6,670
-1,000
| -13% | -$123K | 0.14% | 97 |
|
|
2017
Q1 | $954K | Buy |
7,670
+3,894
| +103% | +$466K | 0.16% | 92 |
|
|
2016
Q4 | $437K | Buy |
3,776
+246
| +7% | +$27.4K | 0.08% | 128 |
|
|
2016
Q3 | $369K | Sell |
3,530
-2,499
| -41% | -$270K | 0.07% | 139 |
|
|
2016
Q2 | $594K | Hold |
6,029
| – | – | 0.12% | 103 |
|
|
2016
Q1 | $603K | Sell |
6,029
-1,564
| -21% | -$161K | 0.11% | 131 |
|
|
2015
Q4 | $909K | Buy |
7,593
+390
| +5% | +$45.1K | 0.15% | 126 |
|
|
2015
Q3 | $779K | Sell |
7,203
-417
| -5% | -$51.7K | 0.13% | 136 |
|
|
2015
Q2 | $882K | Buy |
7,620
+1,200
| +19% | +$137K | 0.13% | 137 |
|
|
2015
Q1 | $740K | Buy |
6,420
+160
| +3% | +$19.1K | 0.11% | 145 |
|
|
2014
Q4 | $700K | Hold |
6,260
| – | – | 0.1% | 153 |
|
|
2014
Q3 | $593K | Hold |
6,260
| – | – | 0.08% | 171 |
|
|
2014
Q2 | $538K | Buy |
6,260
+360
| +6% | +$27.4K | 0.08% | 168 |
|
|
2014
Q1 | $412K | Hold |
5,900
| – | – | 0.07% | 175 |
|
|
2013
Q4 | $498K | Buy |
5,900
+1,200
| +26% | +$95K | 0.08% | 167 |
|
|
2013
Q3 | $362K | Buy |
+4,700
| New | +$329K | 0.07% | 174 |
|
Other funds holding CELG
FP
HCM
PCMC
WCG
Baldwin Wealth Partners's CELG Position: Q4 2019 in Review
Baldwin Wealth Partners sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 771 shares — an estimated $77K sold.
Baldwin Wealth Partners first reported a position in CELG in Q3 2013 and held it in 25 quarters. The position peaked at $970K in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.
- Baldwin Wealth Partners reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
- Baldwin Wealth Partners sold 771 Celgene Corp shares in Q4 2019, an estimated $77K.
- Baldwin Wealth Partners first reported a position in Celgene Corp in Q3 2013 and held it in 25 quarters.
- Baldwin Wealth Partners's Celgene Corp position peaked at $970K in Q3 2017.
- 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.
Based on Baldwin Wealth Partners's 13F filing for Q4 2019, filed 29 Jan 2020.